MedReleaf Corp. Announces $100.7 Million Bought Deal Financing

MedReleaf Corp. (TSX:LEAF) announced today that it has entered into an agreement with Canaccord Genuity Corp. and GMP Securities L.P., pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 3,800,000 units of the Company at a price of $26.50 per Unit for aggregate gross proceeds of $100.7 million.

CannTrust™ Reports Record Revenue for Q4 and FY 2017

CannTrust Holdings Inc. (CSE: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, today is pleased to report preliminary revenue for Q4 and the fiscal year ending December 31, 2017.

Copy of DOJA Cannabis Closes $12.5 Million Private Placement led by Aphria

DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts whereby Aphria Inc. (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39for gross proceeds of $12,500,001.73.

DOJA Cannabis Closes $12.5 Million Private Placement led by Aphria

DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts whereby Aphria Inc. (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39for gross proceeds of $12,500,001.73.

Hydropothecary Announces $100 Million Public Offering

The Hydropothecary Corporation (TSX VENTURE:THCX) announced today that it has entered into an agreement with Canaccord Genuity Corp., Eight Capital, and a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 25,000,000 units of the Company at a price of $4.00 per Unit for aggregate gross proceeds of $100,000,000. Each Unit will consist of one common share and one half of one common share purchase warrant of the Company.

Harvest One Announces $25 Million Bought Short Form Prospectus Offering of Units

Harvest One Cannabis Inc. (TSX VENTURE:HVST) is pleased to announce that is has entered into an agreement with Mackie Research Capital Corporation, on its own behalf and behalf of a syndicate of Underwriters, to complete a $25,000,000 short form prospectus offering of units of the Company on a bought deal basis, at a price of $1.82 per Unit.

Copy of Hydropothecary Announces $100 Million Public Offering

The Hydropothecary Corporation (TSX VENTURE:THCX) announced today that it has entered into an agreement with Canaccord Genuity Corp., Eight Capital, and a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 25,000,000 units of the Company at a price of $4.00 per Unit for aggregate gross proceeds of $100,000,000. Each Unit will consist of one common share and one half of one common share purchase warrant of the Company.

Vermont House votes to legalize marijuana

The Vermont House passed a bill Thursday night to legalize recreational possession of marijuana just hours after Attorney General Jeff Sessions rescinded a Department of Justice policy on legal marijuana.

Canopy Growth Corporation Responds to Department of Justice Update on U.S. Cannabis Laws

In response to news out of the United States Department of Justice yesterday morning regarding federal cannabis laws in the United States and further to press releases issued Oct 17, 2017 and Aug. 4, 2017, Canopy Growth Corporation (TSX: WEED) wishes to reiterate its commitment to only conducting business in jurisdictions where that conduct is federally legal and otherwise in compliance with all applicable laws.